Cargando…

APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels

Precision genome editing has become a reality with the discovery of base editors. Cytosine base editor (CBE) technologies are improving rapidly but are mostly optimized for TC dinucleotide targets. Here, we report the development and implementation of APOBEC Reporter Systems for Evaluating diNucleot...

Descripción completa

Detalles Bibliográficos
Autores principales: Rieffer, Amanda E., Chen, Yanjun, Salamango, Daniel J., Moraes, Sofia N., Harris, Reuben S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611974/
https://www.ncbi.nlm.nih.gov/pubmed/37672599
http://dx.doi.org/10.1089/crispr.2023.0027
_version_ 1785128598506569728
author Rieffer, Amanda E.
Chen, Yanjun
Salamango, Daniel J.
Moraes, Sofia N.
Harris, Reuben S.
author_facet Rieffer, Amanda E.
Chen, Yanjun
Salamango, Daniel J.
Moraes, Sofia N.
Harris, Reuben S.
author_sort Rieffer, Amanda E.
collection PubMed
description Precision genome editing has become a reality with the discovery of base editors. Cytosine base editor (CBE) technologies are improving rapidly but are mostly optimized for TC dinucleotide targets. Here, we report the development and implementation of APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels (ARSENEL) in living cells. The ARSENEL panel is comprised of four constructs that quantitatively report editing of each of the four dinucleotide motifs (AC/CC/GC/TC) through real-time accumulation of eGFP fluorescence. Editing rates of APOBEC3Bctd and AIDΔC CBEs reflect established mechanistic preferences with intrinsic biases to TC and GC, respectively. Twelve different (new and established) base editors are tested here using this system with a full-length APOBEC3B CBE showing the greatest on-target TC specificity and an APOBEC3A construct showing the highest editing efficiency. In addition, ARSENEL enables real-time assessment of natural and synthetic APOBEC inhibitors with the most potent to-date being the large subunit of the Epstein–Barr virus ribonucleotide reductase. These reporters have the potential to play important roles in research and development as precision genome engineering technologies progress toward achieving maximal specificity and efficiency.
format Online
Article
Text
id pubmed-10611974
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Mary Ann Liebert, Inc., publishers
record_format MEDLINE/PubMed
spelling pubmed-106119742023-10-29 APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels Rieffer, Amanda E. Chen, Yanjun Salamango, Daniel J. Moraes, Sofia N. Harris, Reuben S. CRISPR J Research Articles Precision genome editing has become a reality with the discovery of base editors. Cytosine base editor (CBE) technologies are improving rapidly but are mostly optimized for TC dinucleotide targets. Here, we report the development and implementation of APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels (ARSENEL) in living cells. The ARSENEL panel is comprised of four constructs that quantitatively report editing of each of the four dinucleotide motifs (AC/CC/GC/TC) through real-time accumulation of eGFP fluorescence. Editing rates of APOBEC3Bctd and AIDΔC CBEs reflect established mechanistic preferences with intrinsic biases to TC and GC, respectively. Twelve different (new and established) base editors are tested here using this system with a full-length APOBEC3B CBE showing the greatest on-target TC specificity and an APOBEC3A construct showing the highest editing efficiency. In addition, ARSENEL enables real-time assessment of natural and synthetic APOBEC inhibitors with the most potent to-date being the large subunit of the Epstein–Barr virus ribonucleotide reductase. These reporters have the potential to play important roles in research and development as precision genome engineering technologies progress toward achieving maximal specificity and efficiency. Mary Ann Liebert, Inc., publishers 2023-10-01 2023-10-10 /pmc/articles/PMC10611974/ /pubmed/37672599 http://dx.doi.org/10.1089/crispr.2023.0027 Text en © Amanda E. Rieffer et al. 2023; Published by Mary Ann Liebert, Inc. https://creativecommons.org/licenses/by/4.0/This Open Access article is distributed under the terms of the Creative Commons License [CC-BY] (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Rieffer, Amanda E.
Chen, Yanjun
Salamango, Daniel J.
Moraes, Sofia N.
Harris, Reuben S.
APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels
title APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels
title_full APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels
title_fullStr APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels
title_full_unstemmed APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels
title_short APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels
title_sort apobec reporter systems for evaluating dinucleotide editing levels
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611974/
https://www.ncbi.nlm.nih.gov/pubmed/37672599
http://dx.doi.org/10.1089/crispr.2023.0027
work_keys_str_mv AT riefferamandae apobecreportersystemsforevaluatingdinucleotideeditinglevels
AT chenyanjun apobecreportersystemsforevaluatingdinucleotideeditinglevels
AT salamangodanielj apobecreportersystemsforevaluatingdinucleotideeditinglevels
AT moraessofian apobecreportersystemsforevaluatingdinucleotideeditinglevels
AT harrisreubens apobecreportersystemsforevaluatingdinucleotideeditinglevels